SEARL Stock Overview
Manufactures and sells pharmaceutical and other consumer products in Pakistan.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
The Searle Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | PK₨57.69 |
| 52 Week High | PK₨64.09 |
| 52 Week Low | PK₨34.22 |
| Beta | 0.85 |
| 1 Month Change | 7.45% |
| 3 Month Change | 11.13% |
| 1 Year Change | 39.38% |
| 3 Year Change | -63.34% |
| 5 Year Change | -38.54% |
| Change since IPO | 1,405.05% |
Recent News & Updates
Recent updates
Shareholder Returns
| SEARL | PK Pharmaceuticals | PK Market | |
|---|---|---|---|
| 7D | -1.4% | -2.0% | -0.6% |
| 1Y | 39.4% | 67.1% | 60.9% |
Return vs Industry: SEARL underperformed the PK Pharmaceuticals industry which returned 65.4% over the past year.
Return vs Market: SEARL underperformed the PK Market which returned 60% over the past year.
Price Volatility
| SEARL volatility | |
|---|---|
| SEARL Average Weekly Movement | 6.1% |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in PK Market | 7.7% |
| 10% least volatile stocks in PK Market | 3.2% |
Stable Share Price: SEARL has not had significant price volatility in the past 3 months.
Volatility Over Time: SEARL's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1965 | 2,716 | Syed Ahmed | www.searlecompany.com |
The Searle Company Limited manufactures and sells pharmaceutical and other consumer products in Pakistan. The company offers pharmaceutical products in the therapeutic areas of cardiovascular, respiratory care, gastroenterology, pain management, CNS, orthocare, neuropsychiatry, probiotics, antibiotics, and nutritional care. It also provides nutraceutical products, as well as medical devices and disposables.
The Searle Company Limited Fundamentals Summary
| SEARL fundamental statistics | |
|---|---|
| Market cap | PK₨22.27b |
| Earnings (TTM) | -PK₨1.09b |
| Revenue (TTM) | PK₨36.33b |
0.6x
P/S Ratio-20.7x
P/E RatioIs SEARL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SEARL income statement (TTM) | |
|---|---|
| Revenue | PK₨36.33b |
| Cost of Revenue | PK₨23.02b |
| Gross Profit | PK₨13.30b |
| Other Expenses | PK₨14.39b |
| Earnings | -PK₨1.09b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.79 |
| Gross Margin | 36.62% |
| Net Profit Margin | -2.99% |
| Debt/Equity Ratio | 45.0% |
How did SEARL perform over the long term?
See historical performance and comparison